|
1
|
Deschler B and Lübbert M: Acute myeloid
leukemia: Epidemiology and etiology. Cancer. 107:2099–2107. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lo-Coco F, Ammatuna E, Montesinos P and
Sanz MA: Acute promyelocytic leukemia: Recent advances in diagnosis
and management. Semin Oncol. 35:401–409. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Inagaki J, Fukano R, Noguchi M, Kurauchi
K, Tanioka S and Okamura J: Hematopoietic stem cell transplantation
following unsuccessful salvage treatment for relapsed acute
lymphoblastic leukemia in children. Pediatr Blood Cancer.
62:674–679. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cui L, Gao C, Zhang RD, Jiao Y, Li WJ,
Zhao XX, Liu SG, Yue ZX, Zheng HY, Deng GR, et al: Low expressions
of ARS2 and CASP8AP2 predict relapse and poor prognosis in
pediatric acute lymphoblastic leukemia patients treated on China
CCLG-ALL 2008 protocol. Leuk Res. 39:115–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arakawa Y, Koh K, Aoki T, Kubota Y, Oyama
R, Mori M, Hayashi M and Hanada R: Clofarabine-based combination
chemotherapy for relapse and refractory childhood acute
lymphoblastic leukemia. Rinsho Ketsueki. 55:2316–2319.
2014.PubMed/NCBI
|
|
6
|
Bruedigam C, Bagger FO, Heidel FH, Kuhn
Paine C, Guignes S, Song A, Austin R, Vu T, Lee E, Riyat S, et al:
Telomerase inhibition effectively targets mouse and human AML stem
cells and delays relapse following chemotherapy. Cell Stem Cell.
15:775–790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ilyas AM, Ahmad S, Faheem M, Naseer MI,
Kumosani TA, Al-Qahtani MH, Gari M and Ahmed F: Next generation
sequencing of acute myeloid leukemia: Influencing prognosis. BMC
Genomics. 16(Suppl 1): S52015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Itzykson R, Thépot S, Berthon C, Delaunay
J, Bouscary D, Cluzeau T, Turlure P, Prébet T, Dartigeas C,
Marolleau JP, et al: Azacitidine for the treatment of relapsed and
refractory AML in older patients. Leuk Res. 39:124–130. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rashidi A and Cashen AF: A cytogenetic
model predicts relapse risk and survival in patients with acute
myeloid leukemia undergoing hematopoietic stem cell transplantation
in morphologic complete remission. Leuk Res. 39:77–81. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martelli MF, Di Ianni M, Ruggeri L,
Falzetti F, Carotti A, Terenzi A, Pierini A, Massei MS, Amico L,
Urbani E, et al: HLA-haploidentical transplantation with regulatory
and conventional T-cell adoptive immunotherapy prevents acute
leukemia relapse. Blood. 124:638–644. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Byrd JC, Mrozek K, Dodge RK, Carroll AJ,
Edwards CG, Arthur DC, Pettenati MJ, Patil SR, Rao KW, Watson MS,
et al: Cancer and Leukemia Group B (CALGB 8461): Pretreatment
cytogenetic abnormalities are predictive of induction success,
cumulative incidence of relapse, and overall survival in adult
patients with de novo acute myeloid leukemia: Results from Cancer
and Leukemia Group B (CALGB 8461). Blood. 100:4325–4336. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thakkar SG, Fu AZ, Sweetenham JW, McIver
ZA, Mohan SR, Ramsingh G, Advani AS, Sobecks R, Rybicki L, Kalaycio
M and Sekeres MA: Survival and predictors of outcome in patients
with acute leukemia admitted to the intensive care unit. Cancer.
112:2233–2240. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Benyo M, Flasko T, Molnar Z, Kerenyi A,
Batta Z, Jozsa T and Harsfalvi J: Follow-up of thrombin generation
after prostate cancer surgery: Global test for increased
hypercoagulability. PLoS One. 7:e512992012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Diao D, Zhu K, Wang Z, Cheng Y, Li K, Pei
L and Dang C: Prognostic value of the D-dimer test in oesophageal
cancer during the perioperative period. J Surg Oncol. 108:34–41.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kachel P, Trojanowicz B, Sekulla C,
Prenzel H, Dralle H and Hoang-Vu C: Phosphorylation of pyruvate
kinase M2 and lactate dehydrogenase A by fibroblast growth factor
receptor 1 in benign and malignant thyroid tissue. BMC Cancer.
15:1402015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park HY, Suh GY, Jeon K, Koh WJ, Chung MP,
Kim H, Kwon OJ, Kim K, Jang JH, Jung CW, et al: Outcome and
prognostic factors of patients with acute leukemia admitted to the
intensive care unit for septic shock. Leuk Lymphoma. 49:1929–1934.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Criteria for the
diagnosis of acute leukemia of megakaryocyte lineage (M7). A report
of the French-American-British Cooperative Group. Ann Int Med.
103:460–462. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vardiman JW, Thiele J, Arber DA, Brunning
RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM,
Hellström-Lindberg E, Tefferi A and Bloomfield CD: The 2008
revision of the World Health Organization (WHO) classification of
myeloid neoplasms and acute leukemia: Rationale and important
changes. Blood. 114:937–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Danese E, Montagnana M, Cervellin G and
Lippi G: Hypercoagulability, D-dimer and atrial fibrillation: An
overview of biological and clinical evidence. Ann Med. 46:364–371.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee K, Kim JE, Kwon J, Kim I, Yoon SS,
Park S, Han KS and Kim HK: Poor prognosis of hypocoagulability
assessed by thrombin generation assay in disseminated intravascular
coagulation. Blood Coagul Fibrinolysis. 25:241–247. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sartori M, Migliaccio L, Favaretto E, Cini
M, Legnani C, Palareti G and Cosmi B: D-dimer for the diagnosis of
upper extremity deep and superficial venous thrombosis. Thromb Res.
135:673–678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van der Hulle T, Tan M, den Exter PL, Mol
GC, del Iglesias Sol A, van de Ree MA, Huisman MV and Klok FA:
Selective D-dimer testing for the diagnosis of acute deep vein
thrombosis: A validation study. J Thromb Haemost. 11:2184–2186.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoon CW, Kim SJ, Bang OY, Chung CS, Lee KH
and Kim GM: Premorbid warfarin use and lower D-dimer levels are
associated with a spontaneous early improvement in an atrial
fibrillation-related stroke. J Thromb Haemost. 10:2394–2396. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sartori M, Cosmi B, Legnani C, Favaretto
E, Valdré L, Guazzaloca G, Rodorigo G, Cini M and Palareti G: The
Wells rule and D-dimer for the diagnosis of isolated distal deep
vein thrombosis. J Thromb Haemost. 10:2264–2269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han X, Sheng X, Jones HM, Jackson AL,
Kilgore J, Stine JE, Schointuch MN, Zhou C and Bae-Jump VL:
Evaluation of the anti-tumor effects of lactate dehydrogenase
inhibitor galloflavin in endometrial cancer cells. J Hematol Oncol.
8:22015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Augoff K, Hryniewicz-Jankowska A and
Tabola R: Lactate dehydrogenase 5: An old friend and a new hope in
the war on cancer. Cancer Lett. 358:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dowling P, Pollard D, Larkin A, Henry M,
Meleady P, Gately K, O'Byrne K, Barr MP, Lynch V, Ballot J, et al:
Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1
(hnRNPA2B1) in tumour tissue and blood samples from patients
diagnosed with lung cancer. Mol Biosyst. 11:743–752. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choudhry A and DeLoughery TG: Bleeding and
thrombosis in acute promyelocytic leukemia. Am J Hematol.
87:596–603. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang H, Kuo MC, Shih LY, Dunn P, Wang PN,
Wu JH, Lin TL, Hung YS and Tang TC: Clinical bleeding events and
laboratory coagulation profiles in acute promyelocytic leukemia.
Eur J Haematol. 88:321–328. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Asakura H, Takahashi H, Tsuji H,
Matsushita T, Ninomiya H, Honda G, Mimuro J, Eguchi Y, Kitajima I
and Sakata Y: Post-marketing surveillance of thrombomodulin alfa, a
novel treatment of disseminated intravascular coagulation-safety
and efficacy in 1,032 patients with hematologic malignancy. Thromb
Res. 133:364–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mego M, Zuo Z, Gao H, Cohen EN, Giordano
A, Tin S, Anfossi S, Jackson S, Woodward W, Ueno NT, et al:
Circulating tumour cells are linked to plasma D-dimer levels in
patients with metastatic breast cancer. Thromb Haemost.
113:593–598. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gomes M and Khorana AA: Risk assessment
for thrombosis in cancer. Semin Thromb Hemost. 40:319–324. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yanada M, Matsushita T, Suzuki M, Kiyoi H,
Yamamoto K, Kinoshita T, Kojima T, Saito H and Naoe T: Disseminated
intravascular coagulation in acute leukemia: Clinical and
laboratory features at presentation. Eur J Haematol. 77:282–287.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hess EP and Sztajnkrycer MD: Images in
emergency medicine. Acute leukemia with blast crisis, disseminated
intravascular coagulation, and intraparenchymal hemorrhage. Ann
Emerg Med. 46:314–322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tanaka M and Yamanishi H: The expression
of tissue factor antigen and activity on the surface of leukemic
cells. Leuk Res. 17:103–111. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jácomo RH, Santana-Lemos BA, Lima AS,
Assis PA, Lange AP, Figueiredo-Pontes LL, Oliveira LO, Bassi SC,
Benício MT, Baggio MS, et al: Methionine-induced
hyperhomocysteinemia reverts fibrinolytic pathway activation in a
murine model of acute promyelocytic leukemia. Blood. 120:207–213.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Marchetti M, Russo L, Balducci D and
Falanga A: All trans-retinoic acid modulates the procoagulant
activity of human breast cancer cells. Thromb Res. 128:368–374.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Marchetti M, Diani E, ten Cate H and
Falanga A: Characterization of the thrombin generation potential of
leukemic and solid tumor cells by calibrated automated
thrombography. Haematologica. 97:1173–1180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ohkawara H, Ishibashi T, Sugimoto K, Ikeda
K, Ogawa K and Takeishi Y: Membrane type 1-matrix
metalloproteinase/Akt signaling axis modulates TNF-α-induced
procoagulant activity and apoptosis in endothelial cells. PLoS One.
9:e1056972014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Poovassery JS, Sarr D, Smith G, Nagy T and
Moore JM: Malaria-induced murine pregnancy failure: Distinct roles
for IFN-gamma and TNF. J Immunol. 183:5342–5349. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
de Menezes YA, Félix-Silva J, da
Silva-Júnior AA, Rebecchi IM, de Oliveira AS, Uchoa AF and
Fernandes-Pedrosa Mde F: Protein-rich fraction of Cnidoscolus urens
(L.) Arthur leaves: Enzymatic characterization and procoagulant and
fibrinogenolytic activities. Molecules. 19:3552–3569. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gansler J, Preissner KT and Fischer S:
Influence of proinflammatory stimuli on the expression of vascular
ribonuclease 1 in endothelial cells. FASEB J. 28:752–760. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zucker S, Mirza H, Conner CE, Lorenz AF,
Drews MH, Bahou WF and Jesty J: Vascular endothelial growth factor
induces tissue factor and matrix metalloproteinase production in
endothelial cells: Conversion of prothrombin to thrombin results in
progelatinase A activation and cell proliferation. Int J Cancer.
75:780–786. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hawiger J, Veach RA, Liu XY, Timmons S and
Ballard DW: IkappaB kinase complex is an intracellular target for
endotoxic lipopolysaccharide in human monocytic cells. Blood.
94:1711–1716. 1999.PubMed/NCBI
|
|
45
|
Ma J, Duffy MR, Deng L, Dakin RS, Uil T,
Custers J, Kelly SM, McVey JH, Nicklin SA and Baker AH:
Manipulating adenovirus hexon hypervariable loops dictates immune
neutralisation and coagulation factor X-dependent cell interaction
in vitro and in vivo. PLoS Pathog. 11:e10046732015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Velasco F, Torres A, Rojas R, Alvarez MA,
Gomez P and Castillo D: Increase in the D-dimer levels during
treatment in patients with acute myelogenous leukemia. Haemostasis.
22:117–123. 1992.PubMed/NCBI
|
|
47
|
Cortelazzo S, Ponzoni M, Ferreri AJ and
Hoelzer D: Lymphoblastic lymphoma. Crit Rev Oncol Hematol.
79:330–343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rao D, Ghalaut VS, Ghalaut PS and Rao S:
Case series: CSF LDH, proteins and electrolyte levels in patients
of acute lymphocytic leukemia. Clin Chim Acta. 413:1045–1048. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Thomas X, Danaïla C, Le QH, Sebban C,
Troncy J, Charrin C, Lhéritier V, Michallet M, Magaud JP and Fiere
D: Long-term follow-up of patients with newly diagnosed adult acute
lymphoblastic leukemia: A single institution experience of 378
consecutive patients over a 21-year period. Leukemia. 15:1811–1822.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yeh CH, Tseng R, Hannah A, Estrov Z, Estey
E, Kantarjian H and Albitar M: Clinical correlation of circulating
heat shock protein 70 in acute leukemia. Leuk Res. 34:605–609.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Suvajdžić N, Cvetković Z, Dorđević V,
Kraguljac-Kurtović N, Stanisavljević D, Bogdanović A, Djunić I,
Colović N, Vidović A, Elezović I and Tomin D: Prognostic factors
for therapy-related acute myeloid leukaemia (t-AML)-a single centre
experience. Biomed Pharmacother. 66:285–292. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Litzow MR, Othus M, Cripe LD, Gore SD,
Lazarus HM, Lee SJ, Bennett JM, Paietta EM, Dewald GW, Rowe JM, et
al: Failure of three novel regimens to improve outcome for patients
with relapsed or refractory acute myeloid leukaemia: A report from
the Eastern Cooperative Oncology Group. Br J Haematol. 148:217–225.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Shiozawa Y, Takita J, Kato M, Sotomatsu M,
Koh K, Ida K and Hayashi Y: Prognostic significance of leukopenia
in childhood acute lymphoblastic leukemia. Oncol Lett. 7:1169–1174.
2014.PubMed/NCBI
|
|
54
|
Hossain MJ, Xie L and Caywood EH:
Prognostic factors of childhood and adolescent acute myeloid
leukemia (AML) survival: Evidence from four decades of US
population data. Cancer Epidemiol. 39:720–726. 2015. View Article : Google Scholar : PubMed/NCBI
|
